We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Occupational exposure to fluoro-edenite and prevalence of anti-nuclear autoantibodies

    Venerando Rapisarda

    Occupational Medicine, Department of Clinical & Experimental Medicine, University of Catania, Catania, Italy

    Authors contributed equally

    Search for more papers by this author

    ,
    Carla Loreto

    Human Anatomy & Histology, Department of Biomedical & Biotechnology Sciences, University of Catania, Catania, Italy

    Authors contributed equally

    Search for more papers by this author

    ,
    Sergio Castorina

    Human Anatomy & Histology, Department of Biomedical & Biotechnology Sciences, University of Catania, Catania, Italy

    ,
    Gaetano Romano

    Occupational Medicine, Department of Clinical & Experimental Medicine, University of Catania, Catania, Italy

    ,
    Sebastiano Fabio Garozzo

    Clinical Pathology Unit, ‘Garibaldi Centro’ Hospital of Catania, Italy

    ,
    Andrea Musumeci

    Radiology Unit, ‘Policlinico G. Rodolico’ Universitary Hospital of Catania, Catania, Italy

    ,
    Marcello Migliore

    Academic Thoracic Surgery Unit, University Hospital ‘Policlinico-Vittorio Emanuele’, Department of Surgery, University of Catania, Catania, Italy

    ,
    Roberto Avola

    Biochemistry, Department of Biomedical Sciences & Biotechnology, University of Catania, Catania, Italy

    ,
    Diana Cinà

    Clinical Pathology Unit, ‘Garibaldi Centro’ Hospital of Catania, Italy

    ,
    Cristoforo Pomara

    Legal Medicine, Department of Clinical & Experimental Medicine, University of Foggia, Foggia, Italy

    School of Medicine, Department of Anatomy, University of Malta, Msida, Malta

    &
    Caterina Ledda

    *Author for correspondence:

    E-mail Address: cledda@unict.it

    Occupational Medicine, Department of Clinical & Experimental Medicine, University of Catania, Catania, Italy

    Published Online:https://doi.org/10.2217/fon-2017-0389

    An environmental contamination due to an asbestiform mineral fiber, fluoro-edenite (FE), caused a significantly increased mortality rate for malignant mesothelioma in Biancavilla, Italy. Exposure to fluoro-edenite has been associated with inflammatory processes as an early response to inhaled fibers. The aim was to explore prevalence of anti-nuclear autoantibodies (ANA) in a group of construction workers residing and working in the contaminated area. Prevalences for samples positive to ANA were 60% (n = 9) and 13% (n = 2), for exposed and nonexposed, respectively (p-value <0.05), the odds ratio was 9.75 (95% CI: 1.59–59.69). The significance of elevated ANAs in subjects exposed to fibers is unknown; additional studies may provide a better opportunity to establish a correlation between autoimmunity and environmental exposure.

    References

    • 1 Bruno C, Tumino R, Fazzo L et al. Incidence of pleural mesothelioma in a community exposed to fibres with fluoro-edenitic composition in Biancavilla (Sicily, Italy). Ann. Ist. Super Sanita 50(2), 111–118 (2014).
    • 2 Ledda C, Loreto C, Pomara C et al. Sheep lymph-nodes as a biological indicator of environmental exposure to fluoro-edenite. Environ. Res. 147, 97–101 (2016).
    • 3 Rapisarda V, Ledda C, Ricceri V et al. Detection of pleural plaques in workers exposed to inhalation of natural fluoro-edenite fibres. Oncol. Lett. 9(5), 2046–2052 (2015).
    • 4 Ledda C, Pomara C, Bracci M et al. Natural carcinogenic fiber and pleural plaques assessment in a general population: a cross-sectional study. Environ. Res. 150, 23–29 (2016).
    • 5 Ledda C, Loreto C, Bracci M et al. High risk of pleural plaques and parenchymal abnormalities in women living in Biancavilla (Italy). Future Oncol. 12(23s), 63–65 (2016).
    • 6 Grosse Y, Loomis D, Guyton KZ et al. International Agency for Research on Cancer Monograph Working Group. Carcinogenicity of fluoro-edenite, silicon carbide fibers and whiskers, and carbon nanotubes. Lancet. Oncol. 15(13), 1427–1428 (2014).
    • 7 Ledda C, Loreto C, Matera S et al. Early effects of fluoro-edenite: correlation between IL-18 serum levels and pleural and parenchymal abnormalities. Future Oncol. 12(23s), 59–62 (2016).
    • 8 Ledda C, Costa C, Matera S et al. Immunomodulatory effects in workers exposed to naturally occurring asbestos fibers. Mol. Med. Rep. 15, 3372–3378 (2017).
    • 9 Rapisarda V, Caltabiano R, Musumeci G et al. Analysis of fibulin-3 after exposure to asbestos-like fibers. Environ. Res. 156, 381–387 (2017).
    • 10 Rapisarda V, Ledda C, Migliore M et al. FBLN-3 as a biomarker of pleural plaques in workers occupationally exposed to carcinogenic fibers: a pilot study. Future Oncol. 11(24s), 35–37 (2015).
    • 11 Pfau JC, Serve KM, Noonan CW. Autoimmunity and asbestos exposure. Autoimmune Dis. 2014, 782045 (2014).
    • 12 Pfau JC, Sentissi JJ, Weller G et al. Assessment of autoimmune responses associated with asbestos exposure in Libby, Montana, USA. Environ. Health. Perspect. 113(1), 25–30 (2005).
    • 13 Brown JM, Pfau JC, Pershouse MA et al. Silica, apoptosis and autoimmunity. J. Immunotoxicol. 1(3–4), 177–187 (2005).
    • 14 Marchand LS, St-Hilaire S, Putnam EA et al. Mesothelial cell and anti-nuclear autoantibodies associated with pleural abnormalities in an asbestos exposed population of Libby, MT. Toxicol. Lett. 208(2), 168–173 (2012).
    • 15 Tan EM, Feltkamp TEW, Smolen JS et al. Range of antinuclear antibodies in ‘healthy’ individuals. Arthritis. Rheum. 40(9), 1601–1611 (1997).